American depository receipts of European stocks were trading 0.26% higher at 140.79 on the Bank of New York Mellon Europe ADR Index on Wednesday.
In continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ), which jumped 16.6%, followed by Ericsson ( ERIC ), which rose 4.2%. Materialise ( MTLS ), a 3D printer maker, and furniture manufacturer Natuzzi ( NTZ ) were up 3.6% and 3.3% respectively.
The decliners in continental Europe were led by biotech firm argenx ( ARGX ), and telecommunications provider Telecom Italia (TI), which lost 4.2% and 2.7% respectively. They were followed by hotel reservation site Trivago (TRVG), down 2%, and 3D printer maker voxeljet (VJET), down 1.3%.
In the UK and Ireland, the gainers were led by gene therapy company Nightstar (NITE) and Verona Pharma (VRNA), which rose 2.8% and 2.5% respectively. They were followed by biopharmaceutical company Amarin (AMRN), up 0.9%, and HSBC (HSBC), up 1.%.
The decliners in the U.K. and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP), and NuCana (NCNA), which fell 4.8% and 2.8% respectively. They were followed by biotech firm Shire (SHPG), which dropped 1%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
